• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Forced Complementation between Subgenomic RNAs: Does Human Immunodeficiency Type 1 Virus Reverse Transcription Occur in Viral Core, Cytoplasm, or Early Endosome?亚基因组RNA之间的强制互补:1型人类免疫缺陷病毒逆转录是在病毒核心、细胞质还是早期内体中发生?
J AIDS Immune Res. 2015;1(1). Epub 2015 Mar 2.
2
Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His).U5区域内的核苷酸替换对于人类免疫缺陷病毒1型利用与tRNA(His)互补的引物结合位点进行高效逆转录至关重要。
J Virol. 1997 Sep;71(9):6315-22. doi: 10.1128/JVI.71.9.6315-6322.1997.
3
Subcellular Localization of HIV-1 mRNAs Regulates Sites of Virion Assembly.HIV-1信使核糖核酸的亚细胞定位调控病毒体组装位点。
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.02315-16. Print 2017 Mar 15.
4
Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).病毒RNA基因组U5区域内的核苷酸序列是人类免疫缺陷病毒1型维持与tRNA(His)互补的引物结合位点的主要决定因素。
Virology. 1996 Dec 15;226(2):306-17. doi: 10.1006/viro.1996.0658.
5
Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina.不同启动子对恒河猴和豚尾猴中HIV-1 gag/env多基因DNA疫苗引发的免疫反应的影响。
Vaccine. 2000 May 22;18(23):2566-83. doi: 10.1016/s0264-410x(99)00569-1.
6
Transcription strategy in a Closterovirus: a novel 5'-proximal controller element of Citrus Tristeza Virus produces 5'- and 3'-terminal subgenomic RNAs and differs from 3' open reading frame controller elements.一种长线形病毒的转录策略:柑橘衰退病毒的一种新型5'-近端调控元件产生5'-和3'-末端亚基因组RNA,且不同于3'开放阅读框调控元件。
J Virol. 2003 Jan;77(1):340-52. doi: 10.1128/jvi.77.1.340-352.2003.
7
Genetic evidence of the interaction between tRNA(Lys,3) and U5 facilitating efficient initiation of reverse transcription by human immunodeficiency virus type 1.tRNA(Lys,3)与U5之间相互作用促进人类免疫缺陷病毒1型逆转录有效起始的遗传学证据。
AIDS Res Hum Retroviruses. 1998 Jul 20;14(11):979-88. doi: 10.1089/aid.1998.14.979.
8
PF74 Reinforces the HIV-1 Capsid To Impair Reverse Transcription-Induced Uncoating.PF74 增强 HIV-1 衣壳以损害逆转录诱导的脱壳。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.00845-18. Print 2018 Oct 15.
9
Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.人类免疫缺陷病毒1型病毒粒子因病毒体内逆转录继发的形态学变化:有证据表明逆转录可能并非在完整的病毒核心内发生。
J Hum Virol. 2000 May-Jun;3(3):165-72.
10
Exoribonuclease-Resistant RNAs Exist within both Coding and Noncoding Subgenomic RNAs.具有外切核酸酶抗性的 RNA 存在于编码和非编码亚基因组 RNA 内。
mBio. 2018 Dec 18;9(6):e02461-18. doi: 10.1128/mBio.02461-18.

本文引用的文献

1
Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.鉴定改变感染细胞中 HIV-1 脱壳速度的衣壳突变。
J Virol. 2015 Jan;89(1):643-51. doi: 10.1128/JVI.03043-14. Epub 2014 Oct 22.
2
HIV-1 uncoating is facilitated by dynein and kinesin 1.动力蛋白和驱动蛋白1促进了HIV-1衣壳的脱壳。
J Virol. 2014 Dec;88(23):13613-25. doi: 10.1128/JVI.02219-14. Epub 2014 Sep 17.
3
A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation.逆转录病毒基因组 RNA 中的顺式作用元件将 Gag-Pol 核糖体移码与选择性病毒 RNA 包装联系起来。
Cell Host Microbe. 2013 Feb 13;13(2):181-92. doi: 10.1016/j.chom.2013.01.007.
4
Multiple roles of the capsid protein in the early steps of HIV-1 infection.衣壳蛋白在 HIV-1 感染早期的多种作用。
Virus Res. 2012 Dec;170(1-2):15-24. doi: 10.1016/j.virusres.2012.09.012. Epub 2012 Oct 3.
5
Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription.互补实验揭示了 HIV-1 脱壳与逆转录之间的关系。
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9975-80. doi: 10.1073/pnas.1014522108. Epub 2011 May 31.
6
Virus entry by endocytosis.病毒通过内吞作用进入细胞。
Annu Rev Biochem. 2010;79:803-33. doi: 10.1146/annurev-biochem-060208-104626.
7
Maturation of the HIV reverse transcription complex: putting the jigsaw together.HIV 逆转录复合物的成熟:拼好拼图。
Rev Med Virol. 2009 Nov;19(6):324-37. doi: 10.1002/rmv.627.
8
A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates.一种基于酵母的新型重组方法,用于克隆和传播多种HIV-1分离株。
Biotechniques. 2009 May;46(6):458-67. doi: 10.2144/000113119.
9
When is it time for reverse transcription to start and go?什么时候该开始并进行逆转录?
Retrovirology. 2009 Mar 4;6:24. doi: 10.1186/1742-4690-6-24.
10
Calculating HIV-1 infectious titre using a virtual TCID(50) method.使用虚拟半数组织培养感染剂量(TCID₅₀)法计算HIV-1感染滴度。
Methods Mol Biol. 2009;485:27-35. doi: 10.1007/978-1-59745-170-3_3.

亚基因组RNA之间的强制互补:1型人类免疫缺陷病毒逆转录是在病毒核心、细胞质还是早期内体中发生?

Forced Complementation between Subgenomic RNAs: Does Human Immunodeficiency Type 1 Virus Reverse Transcription Occur in Viral Core, Cytoplasm, or Early Endosome?

作者信息

Han Weining, Li Yuejin, Bagaya Bernard S, Tian Meijuan, Chamanian Mastooreh, Zhu Chuanwu, Shen Jie, Gao Yong

机构信息

Suzhou Center for Disease Control and Prevention, Suzhou, China.

Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, 10900, Euclid Ave, Cleveland, Ohio 44106, USA.

出版信息

J AIDS Immune Res. 2015;1(1). Epub 2015 Mar 2.

PMID:27239643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4882926/
Abstract

Although the process of reverse transcription is well elucidated, it remains unclear if viral core disruption provides a more cellular or viral milieu for HIV-1 reverse transcription. We have devised a method to require mixing of viral cores or core constituents to produce infectious progeny virus by a bipartite subgenomic RNA (sgRNA) system, in which HIV-1 cplt_R/U5/gag/Δpol and nfl sgRNAs are complementary to each other and when together can complete viral reverse transcription. Only the heterodiploid virus containing both the nfl and cplt_R/U5/gag/Δpol sgRNAs can complete reverse transcription and propagate infectious virus upon de novo infection. Dual exposure of U87.CD4.CXCR4 cells with high titers of the homodimeric nfl and cplt_R/U5/gag/Δpol virus particles did not result in productive virus infection. On the other hand, in early endosomes, the HIV-1 sgRNAs released from viral cores can retain function and complete the reverse transcription and result in productive infection. These findings confirm the assumptions that, in natural infection, HIV-1 cores, and likely other retrovirus cores, remain largely intact and do not mix/fuse in the cytoplasm during the reverse transcription process, and circulating cytoplasmic HIV-1 sgRNA (produced through transfection) could not help the complementary sgRNA in the viral core to complement the reverse transcription process.

摘要

尽管逆转录过程已得到充分阐明,但尚不清楚病毒核心的破坏为HIV-1逆转录提供的是更具细胞特性还是病毒特性的环境。我们设计了一种方法,通过二分体亚基因组RNA(sgRNA)系统,要求混合病毒核心或核心成分以产生有感染性的子代病毒,其中HIV-1 cplt_R/U5/gag/Δpol和nfl sgRNA相互互补,共同存在时可完成病毒逆转录。只有同时包含nfl和cplt_R/U5/gag/Δpol sgRNA的异源二倍体病毒在初次感染时才能完成逆转录并传播有感染性的病毒。用高滴度的同型二聚体nfl和cplt_R/U5/gag/Δpol病毒颗粒双重感染U87.CD4.CXCR4细胞不会导致有 productive 的病毒感染。另一方面,在早期内体中,从病毒核心释放的HIV-1 sgRNA可保留功能并完成逆转录,从而导致有 productive 的感染。这些发现证实了以下假设:在自然感染中,HIV-1核心以及可能的其他逆转录病毒核心在很大程度上保持完整,在逆转录过程中不会在细胞质中混合/融合,并且循环的细胞质HIV-1 sgRNA(通过转染产生)无法帮助病毒核心中的互补sgRNA完成逆转录过程。 (注:productive 在这里根据语境推测可能是“有成效的、有效的”意思,但原文未明确给出准确释义,翻译可能不太准确,需结合更多背景信息判断。)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/2f58f1657043/nihms723306f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/77a712868329/nihms723306f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/eece18c4ac0e/nihms723306f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/9cbb4e56ad33/nihms723306f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/34325b522be6/nihms723306f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/850f1f09acb7/nihms723306f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/62efc8b04b4d/nihms723306f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/2f58f1657043/nihms723306f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/77a712868329/nihms723306f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/eece18c4ac0e/nihms723306f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/9cbb4e56ad33/nihms723306f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/34325b522be6/nihms723306f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/850f1f09acb7/nihms723306f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/62efc8b04b4d/nihms723306f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d678/4882926/2f58f1657043/nihms723306f7.jpg